Knowledge transfer to boost your profession
A 3-day pharmaceutical conference that features a number of key scientific sessions, workshops, and highly specialized sessions that provide comprehensive content covering various segments of the pharmaceutical industry specially designed for pharmacists and pharma industry professionals.
The 100+ lectures will focus on the drug manufacturing industry while also highlighting the latest policies and regulations governing the administration and safety and efficacy of drugs in the region. The event also provides you with an opportunity to learn and share ideas that will enhance the future of the region’s pharmaceutical and healthcare industry.
A special conference for “Drug Regulatory & Manufacturing “, to address new trends and developments in the Manufacturing and packaging segment and regulations in the market.
87% rated the speakers as Exceptional!
Expert Speaker lineup
Over the course of three days, the DUPHAT conference brings the world’s most renowned, scientific speakers and inspirational business leaders.
Professor and Dean Emeritus Faculty of Pharmaceutical Sciences | Canada
Professor and Dean Emeritus Faculty of Pharmaceutical Sciences
Dr. Sindelar is a Professor and Dean Emeritus, Faculty of Pharmaceutical Sciences, University of British Columbia (UBC). Dr. Sindelar is also an elected fellow of the Canadian Academy of Health Sciences, and an elected fellow of the International Pharmaceutical Federation (FIP). He is Adjunct Professor of Medicinal Chemistry and Adjunct Research Professor of the Research Institute of Pharmaceutical Sciences, The School of Pharmacy, The University of Mississippi. Currently, he serves as the Chair of the FIP “Global Pharmacy Observatory Data & Intelligence Presidential Commission, to provide strategic advice on the development of the Global Pharmaceutical Observatory working with FIP stakeholders including WHO. He is also the Head of Pharmaceutical Sciences, the Athens Institute for Education and Research. Professor Sindelar previously served as Vice President of Innovation, Research & Academic Affairs at Providence Health Care (PHC), President of the PHC Research Institute and Associate Dean Research in the UBC Faculty of Medicine (2013-2016). He is a founder of the Centre for Drug Research and Development (formerly CDRD, now called adMare BioInnovations), a national not-for-profit drug development and commercialization centre. Also, he has served as President of the Global Drug Commercialization Centre (GDCC)-China, and Vice President, GDCC-Worldwide (2017-2019), a translational medicine endeavor that facilitates the innovative development of healthcare initiatives. In these various roles, he continues to contribute to health science research, health policy development, team-building, international partnerships, as well as strategic innovations. Dr. Sindelar completed a M.S. degree and a Ph.D. in Medicinal Chemistry and Natural Products at the University of Iowa School of Pharmacy. His research expertise is in medicinal chemistry, computer-aided drug discovery, and pharmaceutical biotechnology. He is the recipient of several School and University-wide teaching honors and has co-edited 5 editions of the highly successful textbook entitled “Pharmaceutical Biotechnology: Fundamentals and Applications.”
Lectures by this speaker
The Pharmacist and RNA-Based Medicines
11:00 - 12:00
Co-Founder & Chief Executive Officer of Afaq Alwataniyah Company and the Managing Director/Senior Consultant | Saudi Arabia
Co-Founder & Chief Executive Officer of Afaq Alwataniyah Company and the Managing Director/Senior Consultant
Dr. Al-Khars has a Master in Applied Business Research from Swiss Business School, Switzerland; a Master in Business Administration specialized in International Business from the University of Florida, USA and a special diploma degree in new venture creation from the same university. He received a Bachelor degree in Pharmaceutical Science from King Saud University, Riyadh, Saudi Arabia with honor and Master Degree in Clinical Pharmacy from the same university. His academic history includes a Specialty Residency in Pharmacy Practice Management at Detroit Receiving Hospital and Wayne State University, Detroit, Michigan, USA. His research interests include health care quality improvement, health care reform, the economic evaluation of treatment strategies, health care educational system and technologies, and pharmacy practice management. In addition to his teaching and management activities, Dr. Al-Khars has conducted many presentations, executive seminars and management development programs in different countries including Saudi Arabia, USA, Germany, Malaysia, Lebanon, Oman, Egypt, and United Arab Emirates.
Lectures by this speaker
Bridging Gaps and Removing Barriers: Applying 7s Mckinsey Model within Pharmacy Sectors
13:00 - 14:00
Barry A. Bleidt
Professor, Sociobehavioral and Administrative Sciences, College of Pharmacy | USA
Barry A. Bleidt
Professor, Sociobehavioral and Administrative Sciences, College of Pharmacy
Dr. Bleidt is a Professor of Sociobehavioral and Administrative Pharmacy at Nova Southeastern University. He received his BS Pharmacy from the University of Kentucky, PhD in Pharmacy Healthcare Administration from the University of Florida, and his PharmD from Xavier University of Louisiana. Barry has forty years of professional experience in preventing drug use problems and substance misuse. Dr. Bleidt served fourteen years as Chair of the Program Committee for the Alcohol, Tobacco, and Other Drugs Section of the American Public Health Association and five years for the Pharmacy Section, twenty-three years as the parliamentarian of the American Association of Colleges of Pharmacy, and twenty-one years as the Director of Continuing Pharmacy Education for the National Pharmaceutical Association. He has served as a Delegate to the United States Pharmacopoeia Convention since 1985. Dr. Bleidt has delivered over 400 presentations and published nearly fifty works. Some of his publications include the books: Clinical Research in Pharmaceutical Development, Multicultural Pharmaceutical Education, and A Guide to the Top 200 Drugs. Dr. Bleidt was inducted as a Fellow into the APhA Academy of Pharmaceutical Research and Science in 2015. He received the 2013 Chauncey I Cooper Award (the highest honor bestowed by NPhA), 2007 Award for Innovative and Exemplary Contributions to the NPhA Foundation, the Ilene B. Stiff Local Association President’s Award as the leader of the Virginia Pharmacists Association Local Association of the Year (2001), the James M. Tyson Award (2nd Highest Honor from NPhA (2001);and the American Public Health Association Leadership Award from the Alcohol, Tobacco, and Other Drugs Section (2000). He currently resides in Ft. Lauderdale, Florida.
Lectures by this speaker
Pharmacy for Future – The Advance and Impacts
10:00 - 10:45
Chronic Disease State Management
13:00 - 13:45
Professor, Pharmaceutics Former Vice President for Research, Pharco Corporation Former Chairman, National Organization for Drug Control And Research | Egypt
Professor, Pharmaceutics Former Vice President for Research, Pharco Corporation Former Chairman, National Organization for Drug Control And Research
Prof. Molokhia obtained his PhD from the University of Michigan, USA 1973. He held academic positions at Universities of Houston, Riyadh and Alexandria and is a current member of the Egyptian National Pharmacology Committee. He advised more than 52 PhD and MS candidates and co-authored more than 158 original manuscripts and presentations to national and international conferences. Between 1996-2004, he was the chairman of the Egyptian National Organization for Drug Control and Research at the Ministry of Health. From 2004 until 2013, he chaired the European Egyptian Pharmaceutical Industries Company, a division of Pharco Pharmaceuticals, Alexandria, Egypt. Between 2007-2013, he chaired the Pharmaceutical Sector of the Pharmaceuticals and Cosmetic Chamber at the Egyptian Industry Union. Prof. Molokhia chaired several conferences organized among NODCAR, the MOH and the WHO. As consultant to the WHO, he presented training and consultations to nine countries in the EMRO region. Prof. Molokhia co-chaired 5 Egyptian-USP Symposia on “Science and Standards”. He acts as observer representing the Egyptian Chamber of Pharmaceuticals with the USP Convention.
Lectures by this speaker
Drug Supply Chain Threats and Pandemic Impact
11:45 - 12:30
Opportunities in Pharmacoeconomics for Pharmacists at Different Practice Sites
10:00 - 11:00
Vice President, Global Resource Development and Consulting, ASHP | USA
Vice President, Global Resource Development and Consulting, ASHP
Vice President, Global Resource Development and Consulting, ASHP Clinical Professor (Adjunct) University of North Carolina Eshelman School of Pharmacy Professor of Pharmacy Practice Campbell University College of Pharmacy and Health Sciences